Health news
Health news top Health news

   Login  |  Register    
Health News Make AMN Your Home PageDiscussion BoardsAdvanced Search ToolMedical RSS/XML News FeedHealth news
  You are here : Health.am > Health Centers > Arthritis -
Arthritis drug seen to cut heart risk Arthritis drug seen to cut heart risk

Arthritis drug seen to cut heart risk

ArthritisFeb 14, 2005

Methotrexate, used for the treatment of rheumatoid arthritis and psoriasis, may also reduce the risk of Atherosclerosis and circulatory diseases affecting the heart and brain, investigators have found.

As Dr. Robert S. Kirsner told AMN Health, “the finding that treatment of psoriasis—and rheumatoid arthritis—reduced the risk of development of vascular disease...suggests that patients with these diseases may derive benefit from treatment beyond control of their skin and joint disease.”

Kirsner, at the University of Miami, and colleagues note in the American Academy of Dermatology that methotrexate is an analogue of folate and has anti-inflammatory effects that may help reduce vascular disease. However, it may also promote higher levels of a compound called homocysteine, which can increase the risk of vascular disease.

-------------------------------
CELEBREX © is a recent break through in the treatment of osteoarthritis and rheumatioid arthritis.Celebrex ® is being hailed by many as a miracle drug. Celebrex enables people to live more active lives, not limited by arthritis pain.

Order CELEBREX online!
-------------------------------
To see how these two factors balance out in reality, the researchers studied data on 7615 outpatients with psoriasis and 6707 with rheumatoid arthritis who were treated at Veterans Administration facilities in Florida or Puerto Rico.

Those with psoriasis who were prescribed methotrexate had a significantly reduced risk of vascular disease compared with those who were not. The risk was lowest—at 50 percent—in those given a low dose of methotrexate. Similar but less pronounced risk reductions were seen in arthritis patients.

Despite its tendency to adversely affect homocysteine levels, methotrexate therapy “may provide further vasculoprotective benefits.” the researchers conclude.

SOURCE: American Academy of Dermatology, February 2005.

Provided by ArmMed Media
Revision date: June 22, 2011
Last revised: by Andrew G. Epstein, M.D.

Arthritis drug seen to cut heart risk Bookmark this! Arthritis drug seen to cut heart risk

RELATED STORIES:


 Comments [ + Post Your Own

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]




We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.

All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

Please enter the word you see in the image below:


   [advanced search]   
What health info have you recently searched for online?
Disease or condition
Exercise or fitness
Diet, nutrition or vitamins
None of the above


Get free support - Headache Causes, Symptoms, Diagnosis, and Treatment on HeadacheCare.net


Health Centers







Diabetes

















Health news
  


Health Encyclopedia

Diseases & Conditions

Drugs & Medications

Health Tools

Health Tools



   Health newsletter

  





   Medical Links



   RSS/XML News Feed



   Feedback


Add to Yahoo RSS News Feed



Google Reader




Syndicate


This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information:
Verify here.




Urology Problems and Information: Doctor-Reviewed Articles at UrologyToday.net

hit counter